Real-life efficacy of biologicals in patients with severe asthma phenotype overlap. Experiences from a tertiary pulmonary centre

被引：0
|
作者：
Sleiman, Y. [1 ]
Lacwik, P. [1 ,2 ]
Moscicka, A. [1 ]
Ochab-Krupnik, D. [1 ]
Palczynski, C. [2 ]
机构：
[1] Holy Cross Ctr Lung Dis, Checiny, Poland
[2] Jan Kochanowski Univ, Kielce, Poland
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
100524
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-life impact of weight in severe eosinophilic asthma patients treated with benralizumab
    Menzella, Francesco
    Aliani, Maria
    Altieri, Elena
    Bracciale, Pietro
    Centanni, Stefano
    De Michele, Fausto
    Di Marco, Fabiano
    Pelaia, Girolamo
    Romagnoli, Micaela
    Schino, Pietro
    Boarino, Silvia
    Vitiello, Gianfranco
    Rogliani, Paola
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [22] Effect of omalizumab treatment on asthma exacerbations? Real-life results of patients with severe uncontrolled asthma
    Havlucu, Y.
    Yorgancioglu, A.
    Kurhan, F.
    ALLERGY, 2016, 71 : 367 - 367
  • [23] A NATIONWIDE REAL-LIFE STUDY: EXPLORING THE DIFFICULTIES OF CONFIRMING THE ASTHMA DIAGNOSIS IN PATIENTS WITH SEVERE ASTHMA
    von Bulow, A.
    Backer, V.
    Bodtger, U.
    Petersen, N. U. Soes
    Skjold, T.
    Assing, K. Dahl
    Porsbjerg, C.
    THORAX, 2015, 70 : A8 - A8
  • [24] Predictor of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
    Numata, Takanori
    Miyagawa, Hanae
    Okuda, Keitaro
    Utsumi, Hirofumi
    Hashimoto, Mitsuo
    Minagawa, Shunsuke
    Ishikawa, Takeo
    Hara, Hiromichi
    Araya, Jun
    Kuwano, Kazuyoshi
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [25] Treatment Eligibility of Real-Life Mepolizumab-Treated Severe Asthma Patients
    Richards, Levi B.
    van Bragt, Job J. M. H.
    Aarab, Reim
    Longo, Cristina
    Neerincx, Anne H.
    Sont, Jaap K.
    Weersink, Els J. M.
    Braunstahl, Gert-Jan
    Ten Brinke, Anneke
    Bel, Elisabeth H. D.
    Maitland-van der Zee, Anke-Hilse
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (09): : 2999 - +
  • [26] Characteristics of severe asthma patients on biologics: a real-life European registry study
    Principe, Stefania
    Richards, Levi B.
    Hashimoto, Simone
    Kroes, Johannes Anthon
    Van Bragt, Job J. M. H.
    Vijverberg, Susanne J.
    Sont, Jacob K.
    Scichilone, Nicola
    Bieksiene, Kristina
    Ten Brinke, Anneke
    Csoma, Zsuzsanna
    Dahlen, Barbro
    Gemicioglu, Bilun
    Grisle, Ineta
    Kuna, Piotr
    Lazic, Zorica
    Mihaltan, Florin
    Popovic-Grle, Sanja
    Skrgat, Sabina
    Marcon, Alessandro
    Caminati, Marco
    Djukanovic, Ratko
    Porsbjerg, Celeste
    Van der Zee, Anke-Hilse Maitland
    ERJ OPEN RESEARCH, 2023, 9 (03)
  • [27] Effectiveness of Dupilumab in Austrian real-life severe asthma patients with smoking history
    Renner, A.
    Marth, K.
    Patocka, K.
    Idzko, M.
    Breyer-Kohansal, R.
    Pohl, W.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (19-20) : 583 - 584
  • [28] Mepolizumab for the treatment of severe eosinophilic asthma: A real-life study of 27 patients
    Masciopinto, L.
    Lovecchio, A.
    Cascavilla, M. T.
    Laudadio, V
    Frisenda, F. M.
    Pasculli, C.
    Di Girolamo, A.
    Sinisi, A.
    Minenna, E.
    Albanesi, M.
    Di Bona, D.
    Caiaffa, M. F.
    Macchia, L.
    ALLERGY, 2019, 74 : 446 - 446
  • [29] A real-life comparison of patients with severe eosinophilic asthma treated with benralizumab or mepolizumab
    Andersen, Helle H.
    Smidt-Hansen, Torben
    Pedersen, Lene M.
    Skjold, Tina
    Schmid, Johannes
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [30] Biomarkers of eosinophilic airways inflammation in patients with severe asthma: A real-life study
    Sergeeva, G.
    Emelyanov, A.
    Leshenkova, E.
    Znakhurenko, A.
    ALLERGY, 2019, 74 : 387 - 387
12345